Statin treated patients have reduced intraplaque angiogenesis in carotid endarterectomy specimens

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 457-463

  Koutouzis, Michael ^a   Nomikos, Alexandros ^a   Nikolidakis, Savvas ^a   Tzavara, Vasiliki ^a   Andrikopoulos, Vasilios ^a   Nikolaou, Nikolaos ^a   Barbatis, Calypso ^a   Kyriakides, Zenon S ^a  

^a RED CROSS HOSPITAL   (Greece)

Author keywords

Carotid artery; Intraplaque angiogenesis; Statins; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUINDOSTATIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; MEVINOLIN; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; CAPILLARY DENSITY; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; ARTERIOSCLEROSIS; CAROTID ARTERIES; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 34248231748     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.035     Document Type: Article

References (34)

1. Andrews T.C., Ballantyne C.M., Hsia J.A., and Kramer J.H. Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statins. Am J Med 111 (2001) 185-191
2. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. New Engl J Med 335 (1996) 1001-1009
3. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group. New Engl J Med 333 (1995) 1301-1307
4. Scandinavian Simvastatin Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin study group (4S). Lancet 344 (1994) 1383-1389
5. Bonetti P.O., Lerman L.O., Napoli C., and Lerman A. Statin effects beyond lipid lowering-are they clinically relevant?. Eur Heart J 24 (2003) 225-248
6. Imparato A.M., Riles T.S., Mintzer R., and Baumann F.G. The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques. Ann Surg 197 (1983) 195-203
7. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Investigators. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. National Institute of Neurological Disorders and Stroke and Trauma Division. Stroke 22 (1991) 816-817
8. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the committee on vascular lesions of the council on arteriosclerosis: American Heart Association. Circulation 92 (1995) 1355-1374
9. Williams J.K., Sukhova G.K., Herrington D.M., and Libby P. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. J Am Coll Cardiol 31 (1998) 684-691
10. Wilson S.H., Herrmann J., Lerman L.O., et al. Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering. Circulation 105 (2002) 415-418
11. Geiringer E. Intimal vascularization and atherosclerosis. J Pathol Bacteriol 63 (1951) 201-211
12. Barger A.C., Beeuwkes III R., Lainey L.L., and Silverman K.J. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. New Engl J Med 310 (1984) 175-177
13. Falk E., Shah P.K., and Fuster V. Coronary plaque disruption. Circulation 92 (1995) 657-671
14. Mofidi R., Crotty T.B., McCarthy P., Sheehan S.J., Mehigan D., and Keaveny T.V. Association between plaque instability, angiogenesis and symptomatic carotid occlusive disease. Br J Surg 88 (2001) 945-950
15. Schumacher H., Kaiser E., Schnabel P.A., Sykora J., Eckstein H.H., and Allenberg J.R. Immunophenotypic characterisation of carotid plaque: increased amount of inflammatory cells as an independent predictor for ischaemic symptoms. Eur J Vasc Endovasc Surg 21 (2001) 494-501
16. Auerbach R., and Sidky Y.A. Nature of the stimulus leading to lymphocyte-induced angiogenesis. J Immunol 123 (1979) 751-754
17. Kaartinen M., Penttila A., and Kovanen P.T. Mast cells accompany microvessels in human coronary atheromas: implications for intimal neovascularization and hemorrhage. Atherosclerosis 123 (1996) 123-131
18. O'Brien K.D., McDonald T.O., Chait A., Allen M.D., and Alpers C.E. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93 (1996) 672-682
19. Newby A.C., and Zaltsman A.B. Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 41 (1999) 345-360
20. Schonbeck U., Mach F., Sukhova G.K., et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?. Circ Res 81 (1997) 448-454
21. Girona J., La Ville A.E., Sola R., Plana N., and Masana L. Simvastatin decreases aldehyde production derived from lipoprotein oxidation. Am J Cardiol 83 (1999) 846-851
22. Aviram M., Hussein O., Rosenblat M., Schlezinger S., Hayek T., and Keidar S. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. J Cardiovasc Pharmacol 271 (1998) 39-45
23. Kimura M., Kurose I., Russel J., and Granger D.N. Effects of fluvastatin on leukocyte endothelial cell adhesion in hypercholesterolemic rats. Arterioscler Thromb Vasc Biol 17 (1997) 1521-1526
24. Scalia R., Gooszen M.E., Jones S.P., et al. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 103 (2001) 2598-2603
25. Bernini F., Didoni G., Bonfandini G., Bellosta S., and Fumagalli R. Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages. Atherosclerosis 104 (1993) 19-26
26. Wong B., Lumma W.C., Smith A.M., et al. Statins suppress THP-1 cell migration and secretion of matrix metalloproteinase 9 by inhibiting geranygeranylation. J Leukoc Biol 69 (2001) 959-962
27. Moulton K.S., Heller E., Konerding M.A., Flynn E., Palinski W., and Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation 99 (1999) 1726-1732
28. Semenza G.L. Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance. J Clin Invest 108 (2001) 39-40
29. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
30. Inoue M., Itoh H., Ueda M., et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98 (1998) 2108-2116
31. Blann A.D., Belgore F.M., Constans J., Conri C., and Lip G.Y. Plasma vascular endothelial growth factor and its receptor Flt-1 in patients with hyperlipidemia and atherosclerosis and the effects of fluvastatin or fenofibrate. Am J Cardiol 87 (2001) 1160-1163
32. Celletti F.L., Waugh J.M., Amabile P.G., Brendolan A., Hilfiker P.R., and Dake M.D. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nat Med 7 (2001) 425-429
33. McCarthy M.J., Loftus I.M., Thompson M.M., et al. Angiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphology. J Vasc Surg 30 (1999) 261-268
34. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major non-cardiac vascular surgery. Circulation 107 (2003) 1848-1851